MedPath
HSA Product

GASCOVID ADVANCE LIQUID

Product approved by Health Sciences Authority (SG)

Basic Information

GASCOVID ADVANCE LIQUID

SUSPENSION

Regulatory Information

SIN16042P

November 17, 2020

General Sale List

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XA02BX13

Company Information

Hovid Bhd

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Active Ingredients

Potassium Bicarbonate

Strength: 200 MG/10ML

SODIUM ALGINATE

Strength: 1000 MG/10ML

Detailed Information

Contraindications

**BEFORE YOU USE GASCOVID ADVANCE LIQUID** – _WHEN YOU MUST NOT USE IT_ Do not take this medicine if: - You are allergic to sodium alginate, potassium bicarbonate or any of the ingredients listed in the end of this leaflet – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_. - Symptoms do not improve after seven days, the clinical situation should be reviewed. - It causes allergic reactions (possibly delayed) as the medical product contains methyl hydroxybenzoate and propyl hydroxybenzoate. If you are not sure whether you should start taking this medicine, talk to your pharmacist or doctor.

Indication Information

**WHAT GASCOVID ADVANCE LIQUID IS USED FOR** Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn, indigestion occurring to the reflux of stomach contents, for instance, as a result of hiatus hernia, during pregnancy or accompanying reflux oesophagitis.

© Copyright 2025. All Rights Reserved by MedPath